Andrew S. Duff
Analyst · the SEC, which are available on the company's website at www.piperjaffray.com and on the SEC website at www.sec.gov. This call will also include statements regarding certain non-GAAP financial measures. Please refer to the company's earnings release issued today for a reconciliation of these non-GAAP financial measures to the most comparable GAAP measure. The earnings release is available on the Investor Relations page of the company's website or at the SEC website. As a reminder, this call is being recorded. And now I'd like to turn the call over to Mr. Andrew Duff. Mr. Duff, you may begin
Good morning, and thank you for joining us to review our fourth quarter and full year results. On our call this morning, I will spend a few minutes discussing the performance of our various businesses in 2014, followed by Deb's review of the financial results and then I will share some perspective on 2015 before we get into your questions. In 2014, we saw the confluence of strategy, execution and markets drive our best shareholder returns in over a decade. With a return on equity of over 8% and a return on tangible equity of almost 12%, our shareholders reaped the rewards from solid execution of our strategy in markets that range from neutral to accommodative across our diverse businesses. Our performance this year was a culmination of a number of steps we took over the past couple of years. These steps can be grouped into 2 major areas: first, cost and operating discipline; and second, focusing resources on our more differentiated and higher-margin businesses. Relative to cost, a major cost reduction effort in 2011 reduced our baseline non-compensation expenses by about 15%, which enhanced our return and increased our capacity to invest in the business. In terms of operating discipline, we pushed responsibility for profitability deeper into the organization. With this step, we improved our hiring discipline, replaced less productive resources and intensified our efforts toward internal development of our people. The combined efforts on cost and operating discipline resulted in improved productivity and enhanced our operating leverage. Another important aspect of operating discipline was a more comprehensive focus on risk management. Given our use of capital in the business and the volatile markets in which we operate, we felt it was critical to devote additional resources and enhance protocols in this area to mitigate or avoid exposure during episodes of market dislocations, which have occurred from time to time since the financial crisis. The second major area we addressed was to focus our resources, both human and financial capital, on those businesses where we have a competitively differentiated position and which offer higher margins and return on capital. Implicitly, this meant exiting businesses where our margins were consistently challenged, primarily much of our international activities. Over the past couple of years, we've invested in a number of areas that help drive our results this year. These included strengthening our industry-leading healthcare team, growing our consumer team, expanding our advisory business and building out a national footprint for our public finance business. We also continued to strengthen our product offering and distribution capabilities in Asset Management. Clearly, our strategy and execution has improved returns for shareholders. We are confident that our strong performance also positions us to attract and execute on more significant growth opportunities. Producers and firms are drawn to successful platforms. We experienced this firsthand with our acquisitions of Edgeview and Seattle-Northwest in 2013. Our stronger operating performance expands our capacity to add people or acquire larger businesses as opportunities emerge. Based on the quality of our people and the strength of our businesses, we are confident in our ability to continue to execute on new opportunities. Moving on to the performance of our specific businesses this year. I will begin with investment banking, where our team produced their strongest year ever, both our capital raising and advisory activities combined to drive record results. On the capital raising side, investments were made to bolster our biotech team, coupled with our already leading position in medtech, positioned us to participate in the exceptionally strong equity capital raising wave that rolled through the healthcare sector in 2014. Overall, our revenue from capital raising reflected the longest sustained period of accommodative market conditions since 2007. For our advisory business, 2014 represented a breakout year for us. With favorable market conditions, we fully realized the returns from our investments in internal development, selective hiring and the Edgeview acquisition. Our traditionally strong healthcare team registered a great year. Our consumer team, which advised on several marquee transactions, and our expanded middle-market group each made significant contributions to our very strong advisory results. Our equity brokerage business largely met our expectations this year, although it was down year-over-year. The decline was attributable to lackluster market-wide trading volumes for much of the year, coupled with a decline in revenues from strategic trading. Nevertheless, the business remained profitable and has several initiatives underway intended to produce growth in 2015. In public finance, markets for debt issuance were essentially flat year-over-year, while our business was down around 5%. We experienced challenging market conditions in California. That state represents our largest practice built on the strength of our market leadership in secondary education funding. The combination of lower issuance volumes and pressure on underwriting spreads in California created a drag on revenue for our public finance business overall. Strong performance in other markets, including Texas and Kansas and sectors like senior living where we continue to invest resources partially offset the impact of California. Looking at our fixed income brokerage business, our posture towards rates was consistent with the broader market as we entered the year. We expected rates would increase gradually throughout the year, but the trend was not clear. As a result, we generally maintained a neutral stance towards rates in most of our trading books, waiting for a clear direction on rates. The market reacted in a similar fashion as we saw dismal flow activity, with trading concentrated at the short end of the curve. As the year progressed, starting with negative growth in the U.S. in Q1 and followed by a deacceleration in major global economies in the second half of the year, rates actually declined throughout the year. Given our largely neutral bias towards rates, generally, we did not benefit from these declines. Despite the less-than-accommodative markets, we produced year-over-year growth in our fixed income brokerage business through several avenues. First, expansion of our mortgage-backed securities and middle-market teams generated some of the gains. Second, on the strength of our knowledge of municipal markets, we were able to benefit from pockets of inefficiency. Third, our business in 2014 did not experience a period of market dislocation similar to what occurred in mid-2013. Our Asset Management business generally tracked the markets for their strategies throughout the year, with the exception of significant outperformance by our international and MLP strategies. Net new assets for the year were flat across a range of strategies. Our exposure to energy through a dedicated energy fund, our MLP strategies and energy holdings in our domestic strategies created a drag in our performance in the second half of the year. Overall, revenues were up 10% year-over-year, excluding performance fees in 2013. Now I'd like to turn the call over to Deb to review the financial results in more detail.